US 11202770
Liquid tasimelteon formulations and methods of use thereof
granted A61KA61K31/343A61K47/02
Quick answer
US patent 11202770 (Liquid tasimelteon formulations and methods of use thereof) held by VANDA PHARMACEUTICALS INC. expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/343, A61K47/02, A61K47/10, A61K47/26